Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLI vs MRNA✓SelectedUSD · MRNAXLI vs MRNA performance historyLatest closeAs of-3.09%11/20
Stock and ETF performance explorer

XLI vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+53.9%
MRNA return
+153.9%
Excess return
-100.0%
Maximum drawdown
-18.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.1%-2.2%-0.9%-3.0%
7D-7.4%-12.7%+5.3%-7.1%
30D-7.1%-20.7%+13.6%-6.7%
3M-12.8%+46.3%-59.0%-13.5%
6M-7.9%+305.2%-313.2%-14.0%
YTD+1.6%+561.2%-559.6%-9.6%
1Y+7.0%+772.1%-765.1%-7.3%
3Y+53.9%+147.0%-93.0%+40.1%
All+53.9%+153.9%-100.0%+40.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling